echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Distribution of Chinese-made drugs in marketing channels and therapeutic areas to see how companies can exert their power

    Distribution of Chinese-made drugs in marketing channels and therapeutic areas to see how companies can exert their power

    • Last Update: 2020-07-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pharmaceutical Network July 7th This article on the distribution of traditional Chinese medicine in various marketing channels, treatment areas to do an analysisDistribution of sales channels:the share of primary medical institutions increased
    According to the Mine net database statistics, in 2019, the national publichospitals(urban public hospitals, county-level public hospitals) and primary medical institutions (urban community health service centers and township hospitals) selling a total of 137.59 billion yuan, of which the largest urban public hospitals (873.9 billion yuan), the smallest urban community health service centers (69.6 billion yuan)From the distribution of Chinese-made medicine sales, the proportion of public hospitals is much higher than that of primary medical institutionsIn 2019, the proportion of traditional Chinese medicine sales in urban public hospitals was as high as 53.8%, the proportion of county-level public hospitals was 22.5%, while the township health hospitals only 14.4%, the lowest urban community health service centers, only 9.3%But in terms of growth trends, primary health care institutions far outperform public hospitalsIn the distribution of traditional Chinese medicine sales, the proportion of township health hospitals increased from 12.2% in 2013 to 14.4% in 2019, and the proportion of urban community health centers increased from 5.9% in 2013 to 9.3% in 2019The share of public hospitals has not increased or decreased, with the proportion of public hospitals in the city falling from 61.8 percent in 2013 to 53.8 percent in 2019 and down 8 percentage points in six years(Figure 1)the actual situation is the same, auxiliary drug catalog and other adverse policies for traditional Chinese medicine are the first to start in public hospitals, and the more to the grass-roots level, doctors are used to prescription Chinese medicine, patients' feelings towards Chinese medicine are also deeperThis is also related to the guidance of the policy of medical reform, such as the "
    medicinehealth system reform as a symbol of the new medical reform of the recent key implementation plan (2009-2011) " to vigorously promote the of Chinese medicine
    , including ethnic medicine, to provide safe and effective and low-cost services for urban and rural residents ;   Distribution of treatment areas: the growth rate of traditional chinese medicine in cardiovascular blood vessels decreased to -6.8% in addition to the distribution of different marketing channels is very different, the distribution of traditional Chinese medicine in different therapeutic areas is more different, Figure 2 shows the 2018 national public medical institutions, Chinese traditional medicine in each marketing channel 13 therapeutic areas of market share It can be seen that no matter in which marketing channel, cardiovascular and cerebrovascular medicine is the largest proportion, of which the county-level public hospitals accounted for the highest proportion, up to 42.2%, followed by urban community health service center39.5%, township health hospital 38.8% and urban public hospital 34.5% The lowest proportion of cardiovascular medicines in urban public hospitals is due to the limited injection of traditional Chinese medicine, which is used in high-level hospitals   Another area of treatment in which the market share of traditional Chinese medicine is large is respiratory system, with the proportion of traditional Chinese medicine being 22.6% in township hospitals, 17.9% of urban community health service centers, 13.6% of county-level public hospitals and 11.9% of urban public hospitals The highest proportion of traditional Chinese medicines for the treatment of tumors in urban public hospitals is due to the large number of cancer patients flowing to large hospitals as shown in Figure 3, traditional Chinese medicine in the treatment of cardiovascular diseases in the field of important, annual sales have already exceeded 100 billion However, in the field of cardiovascular disease in the field of traditional Chinese medicine, Chinese medicine injections accounted for a large proportion, in recent years, auxiliary drug catalog, key monitoring and new version of the medical insurance catalog have restricted the use of Chinese medicine injections, and although the national version of the key monitoring catalog does not include Chinese medicine, but many local version of the focus monitoring catalog are included in Chinese medicine, especially Chinese medicine injections, such as Shandong Weihai, In places such as Inner Mongolia, sales of traditional Chinese medicines in the cardiovascular field have fallen below 100 billion yuan in recent years, from 111.2 billion yuan in 2017 to 99.1 billion yuan in 2019, and the growth rate has also dropped from 8.5% in 2016 to -6.8% in 2019 with the increasing intensity of the graded diagnosis and treatment policy, the relevant Chinese medicine policy to the grass-roots tilt, in the distribution of traditional Chinese medicine sales, the share of primary medical institutions will be further improved At the same time, traditional Chinese medicine in different areas of treatment also show a very big difference, as a chinese medicine enterprise , in the research and development projects, marketing strategies and enterprise strategy formulation in addition to pay more attention to the needs of primary medical institutions, but also to adapt to the distribution of the field of treatment   This article is originally published by Dr Zhang Nature, reproduced please indicate the author, violators will be investigated! Author's email 5620562@qq.com
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.